300676 華大基因
按盤價 
40.740 +0.060 (+0.147%)
40.740 +0.060 (+0.147%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 1,788,517 | 9.59% | 3,705,385 | 3,866,921 | 4,349,637 | 7,053,151 | |
| 減：營業總成本 | 1,663,446 | 7.09% | 3,833,903 | 4,258,391 | 4,110,929 | 5,895,140 | |
| 其中:營業成本 | 1,046,013 | 15.79% | 2,312,477 | 2,263,225 | 2,179,031 | 3,366,226 | |
| 財務費用 | (20,915) | -67.67% | (61,086) | (50,339) | (45,882) | (8,421) | |
| 資產減值損失 | (9,241) | 30.26% | (197,723) | (242,208) | (26,662) | (318,456) | |
| 公允價值變動收益 | 25,193 | 173.53% | (11,291) | (33,176) | (34,357) | 80,733 | |
| 投資收益 | (5,674) | -130.40% | 12,958 | (43,626) | 1,285 | 307,482 | |
| 其中：對聯營企業和合營企業的投資收益 | (11,680) | -8.53% | (11,289) | (79,546) | (31,542) | 297,911 | |
| 營業利潤 | 61,685 | -675.01% | (593,181) | (874,768) | 150,649 | 1,087,910 | |
| 利潤總額 | 58,531 | -540.10% | (602,339) | (886,115) | 115,536 | 1,006,792 | |
| 減：所得稅費用 | 10,751 | -161.57% | 35,467 | 25,986 | 21,854 | 197,507 | |
| 淨利潤 | 47,780 | 1,048.56% | (637,806) | (912,101) | 93,682 | 809,286 | |
| 減：非控股權益 | 375 | -122.98% | (21,151) | (9,410) | 781 | 6,520 | |
| 股東淨利潤 | 47,405 | 718.24% | (616,655) | (902,691) | 92,900 | 802,765 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.113 | 715.11% | -1.481 | -2.189 | 0.227 | 1.956 | |
| 每股派息 (元) * | -- | -- | -- | -- | 0.100 | 1.000 | |
| 每股淨資產 (元) * | 20.360 | -7.97% | 20.306 | 21.968 | 23.820 | 24.349 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 26/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
